<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404972/" ref="ordinalpos=609&amp;ncbi_uid=4147466&amp;link_uid=PMC3404972" image-link="/pmc/articles/PMC3404972/figure/pone-0041596-g007/" class="imagepopup">Figure 7. LRP5 regulates lung vascular and alveolar development through the Ang-Tie2 <span class="highlight" style="background-color:">pathway</span>..  From: LRP5 Regulates Development of Lung Microvessels and Alveoli through the Angiopoietin-Tie2 <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">Angiogenesis and alveolar formation in the lung can be controlled by LRP5-Tie2 signaling depending on the Ang1/Ang2 ratio. In normal postnatal lung development where Ang1 is dominant, LRP5, an essential component of the canonical Wnt signaling pathway, increases Tie2 expression in ECs and stimulates (downward arrow symbols) neonatal lung vascular and alveolar development. However, LRP5-Tie2 signaling inhibits (T-bar symbol) vascular and alveolar development when the lungs are exposed to hyperoxia in which Ang2 is upregulated.</div></div>